Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Indonesian Biomedical Journal is Scopus-indexed (Q3, CiteScore 1.6), WoS ESCI, DOAJ. Published by Prodia Education and Research Institute.
Checked against the index lists dated .
ISSN 2085-3297Verify ISSN ↗2355-9179Verify ISSN ↗
Publisher: Prodia Education and Research Institute
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 277 / 466 | 40th | Q3 |
| Biochemistry, Genetics and Molecular Biology (all) | 153 / 223 | 31st | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2017–present, best quartile Q3, CiteScore 1.6.
Indonesian Biomedical Journal is Q3 in Medicine (miscellaneous) (rank 277 of 466) and Q3 in Biochemistry, Genetics and Molecular Biology (all) (rank 153 of 223), by CiteScore 2025.
Indonesian Biomedical Journal is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.6, which places it in quartile Q3 at the 40th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.237, quartile Q3, with an H-index of 13.
The publisher lists an article processing charge of about US$200 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Indonesian Biomedical Journal is published by Prodia Education and Research Institute. Its print ISSN is 2085-3297 and its online ISSN is 2355-9179.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Indonesian Biomedical Journal has an h-index of 17 and a 2-year mean of 0.73 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #284 of 451 Scopus journals in Medicine (miscellaneous).
Indonesian Biomedical Journal published 60 papers in 2025; its busiest recent year was 2023 with 60. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from Indonesia (85.8%), Iraq (5%) and Malaysia (3.5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.